MT Cancer Inst Fndtn; MT Can Spec
Missoula, Montana, United States
Cancer treatment center in Missoula, Montana
500 W Broadway St, Missoula, MT 59802
About MT Cancer Inst Fndtn; MT Can Spec
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MT Cancer Inst Fndtn; MT Can Spec
During the past decade, MT Cancer Inst Fndtn; MT Can Spec conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis
2002-04-01
2004-01-01
Completed
261
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
2004-07-01
2008-10-01
Terminated
626
Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy
2003-12-01
Completed
240
A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer
2005-01-01
2006-11-01
Completed
460
Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
2003-10-01
2008-03-01
Terminated
63
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MT Cancer Inst Fndtn; MT Can Spec"
#1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at MT Cancer Inst Fndtn; MT Can Spec
According to Clinical.Site data, the most researched conditions in "MT Cancer Inst Fndtn; MT Can Spec" are
"Lymphoma, B-Cell" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "MT Cancer Inst Fndtn; MT Can Spec" in a lesser frequency.
Clinical Trials Intervention Types at MT Cancer Inst Fndtn; MT Can Spec
Most popular intervention types in "MT Cancer Inst Fndtn; MT Can Spec" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bendamustine" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials), "Obinutuzumab" (1 trials) and "Prednisone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MT Cancer Inst Fndtn; MT Can Spec
The vast majority of trials in "MT Cancer Inst Fndtn; MT Can Spec" are
2 trials for "All" genders.
Clinical Trials Status at MT Cancer Inst Fndtn; MT Can Spec
Currently, there are NaN active trials in "MT Cancer Inst Fndtn; MT Can Spec".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in MT Cancer Inst Fndtn; MT Can Spec,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MT Cancer Inst Fndtn; MT Can Spec, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".